You have full text access to this OnlineOpen article

Hepatology

Cover image for Hepatology

June 2010

Volume 51, Issue 6

Pages 1869–2238

  1. Master's Perspective

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
  2. Editorials

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
    2. You have full text access to this OnlineOpen article
      “Neonatal hemochromatosis”: A re-vision (pages 1888–1889)

      A. S. Knisely and Diego Vergani

      Article first published online: 23 APR 2010 | DOI: 10.1002/hep.23728

    3. You have free access to this content
    4. You have full text access to this OnlineOpen article
  3. Viral Hepatitis

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
      Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin (pages 1897–1903)

      Moises Diago, Mitchell L. Shiffman, Jean-Pierre Bronowicki, Stefan Zeuzem, Maribel Rodriguez-Torres, Stephen C. Pappas, Andreas Tietz and David R. Nelson

      Article first published online: 27 JAN 2010 | DOI: 10.1002/hep.23531

    2. You have full text access to this OnlineOpen article
      Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection (pages 1904–1911)

      Josephine H. Li, Xiang Qian Lao, Hans L. Tillmann, Jennifer Rowell, Keyur Patel, Alexander Thompson, Sunil Suchindran, Andrew J. Muir, John R. Guyton, Stephen D. Gardner, John G. McHutchison and Jeanette J. McCarthy

      Article first published online: 12 FEB 2010 | DOI: 10.1002/hep.23592

    3. You have full text access to this OnlineOpen article
      Multiple effects of silymarin on the hepatitis C virus lifecycle (pages 1912–1921)

      Jessica Wagoner, Amina Negash, Olivia J. Kane, Laura E. Martinez, Yaakov Nahmias, Nigel Bourne, David M. Owen, Joe Grove, Claire Brimacombe, Jane A. McKeating, Eve-Isabelle Pécheur, Tyler N. Graf, Nicholas H. Oberlies, Volker Lohmann, Feng Cao, John E. Tavis and Stephen J. Polyak

      Article first published online: 12 FEB 2010 | DOI: 10.1002/hep.23587

    4. You have full text access to this OnlineOpen article
      Primary hepatocyte culture supports hepatitis C virus replication: A model for infection-associated hepatocarcinogenesis (pages 1922–1932)

      Krishna Banaudha, Jan M. Orenstein, Tamara Korolnek, Georges C. St. Laurent III, Takaji Wakita and Ajit Kumar

      Article first published online: 23 FEB 2010 | DOI: 10.1002/hep.23616

      Corrected by:

      Correction: Erratum: Primary hepatocyte culture supports hepatitis C virus replication: A model for infection-associated hepatocarcinogenesis

      Vol. 53, Issue 2, 720, Article first published online: 27 JAN 2011

    5. You have full text access to this OnlineOpen article
      Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers (pages 1933–1944)

      Alexander J.V. Thompson, Tin Nguyen, David Iser, Anna Ayres, Kathy Jackson, Margaret Littlejohn, John Slavin, Scott Bowden, Edward J. Gane, William Abbott, George K.K. Lau, Sharon R. Lewin, Kumar Visvanathan, Paul V. Desmond and Stephen A. Locarnini

      Article first published online: 1 FEB 2010 | DOI: 10.1002/hep.23571

    6. You have full text access to this OnlineOpen article
      Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B (pages 1945–1953)

      Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Kenneth Kar-Lung Yan, Angel Mei-Ling Chim, Hoi-Yun Chan, Chi-Hang Tse, Paul Cheung-Lung Choi, Anthony Wing-Hung Chan, Joseph Jao-Yiu Sung and Henry Lik-Yuen Chan

      Article first published online: 1 FEB 2010 | DOI: 10.1002/hep.23568

    7. You have full text access to this OnlineOpen article
      Hepatitis B virus replication in primary macaque hepatocytes: Crossing the species barrier toward a new small primate model (pages 1954–1960)

      Julie Lucifora, Isabelle E. Vincent, Pascale Berthillon, Tatiana Dupinay, Maud Michelet, Ulrike Protzer, Fabien Zoulim, David Durantel, Christian Trepo and Isabelle Chemin

      Article first published online: 19 FEB 2010 | DOI: 10.1002/hep.23602

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
      Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease (pages 1961–1971)

      Manal F. Abdelmalek, Ayako Suzuki, Cynthia Guy, Aynur Unalp-Arida, Ryan Colvin, Richard J. Johnson, Anna Mae Diehl and for the Nonalcoholic Steatohepatitis Clinical Research Network

      Article first published online: 28 JAN 2010 | DOI: 10.1002/hep.23535

    2. You have free access to this content
      The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis (pages 1972–1978)

      Mustafa S. Ascha, Ibrahim A. Hanouneh, Rocio Lopez, Tarek Abu-Rajab Tamimi, Ariel F. Feldstein and Nizar N. Zein

      Article first published online: 27 JAN 2010 | DOI: 10.1002/hep.23527

    3. You have full text access to this OnlineOpen article
      Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study (pages 1979–1987)

      Elizabeth K. Speliotes, Joseph M. Massaro, Udo Hoffmann, Ramachandran S. Vasan, James B. Meigs, Dushyant V. Sahani, Joel N. Hirschhorn, Christopher J. O'Donnell and Caroline S. Fox

      Article first published online: 12 FEB 2010 | DOI: 10.1002/hep.23593

    4. You have full text access to this OnlineOpen article
      Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis (pages 1988–1997)

      Stuart F. W. Kendrick, Graeme O'Boyle, Jelena Mann, Mujdat Zeybel, Jeremy Palmer, David E. J. Jones and Chris P. Day

      Article first published online: 1 FEB 2010 | DOI: 10.1002/hep.23572

    5. You have full text access to this OnlineOpen article
      Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease (pages 1998–2007)

      Wing-Kin Syn, Ye Htun Oo, Thiago A. Pereira, Gamze F. Karaca, Youngmi Jung, Alessia Omenetti, Rafal P. Witek, Steve S. Choi, Cynthia D. Guy, Caitlin M. Fearing, Vanessa Teaberry, Fausto E.L. Pereira, David H. Adams and Anna Mae Diehl

      Article first published online: 19 FEB 2010 | DOI: 10.1002/hep.23599

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
      Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro (pages 2008–2019)

      Jun Yu, Bo Shen, Eagle S. H. Chu, Narci Teoh, Kin-Fai Cheung, Chung-Wah Wu, Shiyan Wang, Cleo N. Y. Lam, Hai Feng, Junhong Zhao, Alfred S. L. Cheng, Ka-Fai To, Henry L. Y. Chan and Joseph J. Y. Sung

      Article first published online: 28 JAN 2010 | DOI: 10.1002/hep.23550

    2. You have full text access to this OnlineOpen article
      Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound (pages 2020–2029)

      Ramón Vilana, Alejandro Forner, Luis Bianchi, Ángeles García-Criado, Jordi Rimola, Carlos Rodríguez de Lope, María Reig, Carmen Ayuso, Concepció Brú and Jordi Bruix

      Article first published online: 19 FEB 2010 | DOI: 10.1002/hep.23600

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
      CX3CR1 and vascular adhesion protein-1-dependent recruitment of CD16+ monocytes across human liver sinusoidal endothelium (pages 2030–2039)

      Alexander I. Aspinall, Stuart M. Curbishley, Patricia F. Lalor, Chris J. Weston, Miroslava Blahova, Evaggelia Liaskou, Rebecca M. Adams, Andrew P. Holt and David H. Adams

      Article first published online: 12 FEB 2010 | DOI: 10.1002/hep.23591

    2. You have full text access to this OnlineOpen article
      Drug-induced autoimmune hepatitis: Clinical characteristics and prognosis (pages 2040–2048)

      Einar Björnsson, Jayant Talwalkar, Sombat Treeprasertsuk, Patrick S. Kamath, Naoki Takahashi, Schuyler Sanderson, Matthias Neuhauser and Keith Lindor

      Article first published online: 12 FEB 2010 | DOI: 10.1002/hep.23588

    3. You have full text access to this OnlineOpen article
      A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells (pages 2049–2060)

      Patricia M. Verhulst, Lieke M. van der Velden, Viola Oorschot, Ernst E. van Faassen, Judith Klumperman, Roderick H. J. Houwen, Thomas G. Pomorski, Joost C. M. Holthuis and Leo W. J. Klomp

      Article first published online: 12 FEB 2010 | DOI: 10.1002/hep.23586

    4. You have full text access to this OnlineOpen article
      Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade (pages 2061–2068)

      Xiaomin Pan, Susan Kelly, Hector Melin-Aldana, Padmini Malladi and Peter F. Whitington

      Article first published online: 3 FEB 2010 | DOI: 10.1002/hep.23581

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have free access to this content
      Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus–induced cirrhosis. A 12-year prospective follow-up study (pages 2069–2076)

      Savino Bruno, Andrea Crosignani, Corinna Facciotto, Sonia Rossi, Luigi Roffi, Alessandro Redaelli, Roberto de Franchis, Piero Luigi Almasio and Patrick Maisonneuve

      Article first published online: 27 JAN 2010 | DOI: 10.1002/hep.23528

    2. You have full text access to this OnlineOpen article
      Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis (pages 2077–2085)

      Brendan M. McGuire, Igor A. Zupanets, Mark E. Lowe, Xunjun Xiao, Vasyliy A. Syplyviy, Jon Monteleone, Sharron Gargosky, Klara Dickinson, Antonia Martinez, Masoud Mokhtarani and Bruce F. Scharschmidt

      Article first published online: 12 FEB 2010 | DOI: 10.1002/hep.23589

    3. You have full text access to this OnlineOpen article
      Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis (pages 2086–2096)

      Christian J. Steib, Manfred Bilzer, Mark op den Winkel, Susanne Pfeiler, Anna C. Hartmann, Martin Hennenberg, Burkhard Göke and Alexander L. Gerbes

      Article first published online: 19 FEB 2010 | DOI: 10.1002/hep.23596

    4. You have full text access to this OnlineOpen article
      Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis (pages 2097–2107)

      Moreshwar S. Desai, Zainuer Shabier, Michael Taylor, Fong Lam, Sundararajah Thevananther, Astrid Kosters and Saul J. Karpen

      Article first published online: 8 FEB 2010 | DOI: 10.1002/hep.23585

    5. You have full text access to this OnlineOpen article
      Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: A clinical-hemodynamic correlation study (pages 2108–2116)

      Vincenzo La Mura, Juan G. Abraldes, Annalisa Berzigotti, Eva Erice, Alexandra Flores-Arroyo, Juan Carlos García-Pagán and Jaime Bosch

      Article first published online: 23 FEB 2010 | DOI: 10.1002/hep.23612

    6. You have full text access to this OnlineOpen article
      Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method (pages 2117–2126)

      Don C. Rockey, Leonard B. Seeff, James Rochon, James Freston, Naga Chalasani, Maurizio Bonacini, Robert J. Fontana, Paul H. Hayashi and for the US Drug-Induced Liver Injury Network

      Article first published online: 3 FEB 2010 | DOI: 10.1002/hep.23577

  8. Liver Injury/Regeneration

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
      Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury (pages 2127–2139)

      Barbara A. Wetmore, Dominique J. Brees, Reetu Singh, Paul B. Watkins, Melvin E. Andersen, James Loy and Russell S. Thomas

      Article first published online: 3 FEB 2010 | DOI: 10.1002/hep.23574

    2. You have full text access to this OnlineOpen article
      Preapoptotic cell stress response of primary hepatocytes (pages 2140–2151)

      Damijan Nipič, Aleš Pirc, Blaž Banič, Dušan Šuput and Irina Milisav

      Article first published online: 19 FEB 2010 | DOI: 10.1002/hep.23598

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
      S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes (pages 2152–2161)

      Maria Lauda Tomasi, Komal Ramani, Fernando Lopitz-Otsoa, Manuel S. Rodríguez, Tony W. H. Li, Kwangsuk Ko, Heping Yang, Fawzia Bardag-Gorce, Ainhoa Iglesias-Ara, Francesco Feo, Maria Rosa Pascale, José M. Mato and Shelly C. Lu

      Article first published online: 27 JAN 2010 | DOI: 10.1002/hep.23530

    2. You have full text access to this OnlineOpen article
    3. You have full text access to this OnlineOpen article
      Colon carcinoma cell interaction with liver sinusoidal endothelium inhibits organ-specific antitumor immunity through interleukin-1-induced mannose receptor in mice (pages 2172–2182)

      Beatriz Arteta, Nerea Lasuen, Aritz Lopategi, Baldur Sveinbjörnsson, Bård Smedsrød and Fernando Vidal-Vanaclocha

      Article first published online: 12 FEB 2010 | DOI: 10.1002/hep.23590

    4. You have full text access to this OnlineOpen article
      Roles of hypoxia-inducible factor-1α (HIF-1α) versus HIF-2α in the survival of hepatocellular tumor spheroids (pages 2183–2192)

      Heidi Menrad, Christian Werno, Tobias Schmid, Ekaterini Copanaki, Thomas Deller, Nathalie Dehne and Bernhard Brüne

      Article first published online: 19 FEB 2010 | DOI: 10.1002/hep.23597

  10. AASLD Practice Guidelines

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have free access to this content
      Diagnosis and management of autoimmune hepatitis (pages 2193–2213)

      Michael P. Manns, Albert J. Czaja, James D. Gorham, Edward L. Krawitt, Giorgina Mieli-Vergani, Diego Vergani and John M. Vierling

      Article first published online: 8 FEB 2010 | DOI: 10.1002/hep.23584

  11. Diagnostic and Therapeutic Advances in Hepatology

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
  12. Image of the Month

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
  13. Hepatology Elsewhere

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
      c-Jun NH2-terminal kinase 1 in hepatocytes: An essential mediator of insulin resistance (pages 2221–2223)

      Francisco Javier Cubero, Oliver Drvarov and Christian Trautwein

      Article first published online: 23 MAY 2010 | DOI: 10.1002/hep.23737

    2. You have full text access to this OnlineOpen article
  14. Correspondence

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. AASLD Practice Guidelines
    12. Diagnostic and Therapeutic Advances in Hepatology
    13. Image of the Month
    14. Hepatology Elsewhere
    15. Correspondence
    1. You have full text access to this OnlineOpen article
    2. You have full text access to this OnlineOpen article
      Reply: (page 2227)

      Dr. Peter V. E. van den Berghe, Dr. Roderick H. J. Houwen and Dr. Leo W. J. Klomp

      Article first published online: 6 APR 2010 | DOI: 10.1002/hep.23705

    3. You have full text access to this OnlineOpen article
    4. You have full text access to this OnlineOpen article
      Reply: (page 2228)

      Inge Mannaerts and Leo van Grunsven

      Article first published online: 6 APR 2010 | DOI: 10.1002/hep.23704

    5. You have full text access to this OnlineOpen article
    6. You have full text access to this OnlineOpen article
    7. You have full text access to this OnlineOpen article
      Reply: (page 2230)

      Salvatore Petta and Antonio Craxì

      Article first published online: 28 APR 2010 | DOI: 10.1002/hep.23736

    8. You have full text access to this OnlineOpen article
      Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients (page 2231)

      Ezequiel Ridruejo, Raúl Adrover, Daniel Cocozzella, María Virgina Reggiardo and Nora Fernández

      Article first published online: 14 APR 2010 | DOI: 10.1002/hep.23714

    9. You have full text access to this OnlineOpen article
      Reply: (pages 2231–2232)

      John F. Reinus and Allan W. Wolkoff

      Article first published online: 28 APR 2010 | DOI: 10.1002/hep.23735

    10. You have full text access to this OnlineOpen article
    11. You have full text access to this OnlineOpen article
    12. You have full text access to this OnlineOpen article
    13. You have full text access to this OnlineOpen article
    14. You have full text access to this OnlineOpen article
    15. You have full text access to this OnlineOpen article
    16. You have full text access to this OnlineOpen article

SEARCH

SEARCH BY CITATION